Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease

Rheumatology (Oxford). 2020 Jul 1;59(7):1769-1770. doi: 10.1093/rheumatology/keaa217.

Authors

Silvia Piantoni¹, Andrea Patroni², Paola Toniati¹, Roberto Furloni³, Franco Franceschini¹, Laura Andreoli¹, Mirko Scarsi³

Affiliations

¹ Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Brescia.
² Hospital Infection Committee (CIO).
³ Internal Medicine Unit, ASST Valcamonica, Esine (Brescia), Italy.

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus
COVID-19
Colchicine
Coronavirus Infections*
Humans
Pandemics
Pneumonia, Viral*
SARS-CoV-2

Substances

Colchicine